Renal involvement in progressive scleroderma;Nierenbeteiligung bei progressiver Sklerodermie

Deutsche Medizinische Wochenschrift

Volumn 122, Issue 7, 1997, Pages 200-204

  Blumenstein, M ^a,b   Sorodoc, J ^a,b   Weiss, M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Klinik Augustinum Munchen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ANEMIA; HUMAN; KIDNEY DISEASE; MICROANGIOPATHY; REVIEW; SCLERODERMA; THROMBOCYTOPENIA;

EID: 0031055507     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1047597     Document Type: Review

References (22)

1. Copley, J. B., B. J. Smith: Continous ambulatory peritoneal dialysis and scleroderma. Nephron 40 (1985), 353-356.
2. D'Agati, V. D., P. J. Cannon: Scleroderma (systemic sclerosis). In Fischer, C. C., B. M. Brenner (Ed.): Renal Pathology, Vol. 2 (J. B. Lipincott: Philadelphia, 1994), 1058-1086.
3. D'Angelo, W. A., J. F. Fries, A. T. Masi, L. E. Shulman: Pathologic observations in systemic sclerosis. Amer. J. Med. 46 (1969), 428-440.
4. Donohoe, J. F.: Scleroderma and the kidney. Kidney Int. 41 (1992), 462-477.
5. Dzau, V. J.: Significance of the vascular renin-angiotensin pathway. Hypertension 8 (1986), 553-559
6. Gavras, H., I. Gavras, P. J. Cannon, H. R. Brunner, J. H. Laragh: Is elevated plasma renin activity of prognostic importance in systemic sclerosis? Arch. intern. Med. 137 (1977), 1554-1558.
7. Gilliland, B. C.: Systemic sclerosis (scleroderma). In Isselbacher, K. J., E. Braunwald, J. D. Wilson, J. B. Martin, A. S. Fauci, D. L. Kasper (Ed.): Harrison's Principles of Internal Medicine, Vol. II, (Mc Graw Hill, New York [International Edition], 1994), 1655-1661.
8. Haunstein, U. F., M. Albrecht: Epidemiologie und Klinik der systemischen Sklerodermie. H+G, Zeitschrift für Hautkrankheiten, Band 68, Heft 10 (1993), 651-658.
9. Heptinstall, R. H.: Hemolytic uremic syndrome, thrombotic thrombozytopenic purpura, and systemic sclerosis (systemic scleroderma). In Heptinstall, R. H.: Pathology of the kidney, Vol. 2 (Little Brown and Company: Boston 1992), 1202-1233.
10. Knock, G. A., G. Terenghi, C. B. Bunker, H. A. Bull, P. M. Dowd, J. M. Polak: Characterisation of endothelin-binding sites in human skin and their regulation in primary Raynaud-phenomenon and systemic sclerosis. J. Invest. Dermatol. 101 (1993), 73-78.
11. Kovalchik, M.T. S.J. Guggenheim, M.H. Silverman, J. S. Robertson, J. C. Steigerwaldt: The kidney in progressive systemic sclerosis. A prospective study. Ann. Intern. Med. 89 (1978), 881-887.
12. Lakkis, F., O. C. Campbell, K. F. Badr: Systemic sclerosis. In Brenner B. M. (Ed.): The Kidney, Vol. II (W. B. Saunders: Philadelphia 1995), 1717-1729.
13. London, R. D., S. H. Dikman, H. Spiera: Recovery of renal function in undifferentiated connective tissue disease after treatment with angiotensin-converting enzyme inhibitors. Amer. J. Kidney Dis. 18 (1991), 716-721.
14. Medsger, T. A., A. T. Masi, G. P. Rodnan, T. G. Benedek, H. Robinson: Survival with systemic sclerosis (scleroderma): A life table analysis of clinical and demographic factors in 353 male U.S. veteran patients. J. chron. Dis. 26 (1973), 647-660.
15. Nisseson, A. R., F. K. Port: Outcome of end-stage renal disease in patients with rare causes of renal failure. Systemic/vascular disorders. Quart. J. Med. 273 (1990), 63-74.
16. Richardson, J. A.: Hemodialysis and kidney transplantation for renal failure from scleroderma. Arthr. and Rheum. 16 (1973), 265-271.
17. Rosenbloom, J., G. Feldman, B. Freundlich, S. A. Jimenez: Inhibition of excessive scleroderma fibroblast collagen production by recombinant gamma-interferon. Arthr. and Rheum. 29 (1986), 851-856.
18. Schubert G. E.: Niere bei systemischer Sklerodermie. In Remmle, W. (Hrsg.): Pathologie (Springer: Berlin, 1984), 43.
19. Smiley J. D.: Southwestern Internal Medicine Conference. The many faces of sclerodermia. Amer. J. Med. Sci. 304 (1992), 319-333.
20. Steen V. D., J. P. Constantino, A. P. Shapiro, T. A. Medsger: Outcome of renal crisis in systemic sclerosis. Relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann. intern. Med. 113 (1990), 352-357.
21. Tan, E. M., G. P. Rodnan , I. Garcia, Y. Meroi, J. J. Fritzler, C. Peebles: Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthr. and Rheum. 23 (1980), 617-625.
22. Woodhall P. B., R. C. McCoy, J. C. Gunnels, H. F. Seigler: Apparent reccurence of progressive systemic sclerosis in a renal allograft. J. Amer. Med. Ass. 236 (1976), 1032-1034.